Looking Beyond Plaque Psoriasis: Novel IL-36 Inhibitor for Prevention of Generalized Pustular Psoriasis Flares
Review the approval of intravenous spesolimab for generalized pustular psoriasis (GPP) treatment by regulatory authorities. Gain valuable insights from a